Patient Razia Begum admitted under Dr P.S vijayender Sir (203A) Ca Right Breast with liver and bone mets K/c/o HTN, Type2 DM, HbsAg+ Admitted with complaints of pain at the right breast and tight arm , poor oral intake Now c/o mild pain at right breast Vitals BP 130/90mmHG SPO2 95% on RA PR 65bpm TEMP 99.3F RR 26c/min GRBS 191mg/dl Rx 1. Inj Fentanyl CIVI @2ml/hr 2. Inj Ketorolac 30mg iv bd Correct this

Here is the corrected clinical note for patient Razia Begum:

Patient: Razia Begum Consultant: Dr. P.S. Vijayender (Ward 203A) Date: 09/07/2026

Diagnosis:
  • Carcinoma Right Breast with Liver and Bone Metastases
  • Known case of Hypertension, Type 2 Diabetes Mellitus
  • HBsAg Positive (Hepatitis B carrier)

Presenting Complaints (at admission):
  • Pain at right breast and right arm
  • Poor oral intake
Current Complaints:
  • Mild pain at right breast

Vitals:
ParameterValueInterpretation
BP130/90 mmHgAcceptable (HTN - controlled)
SpO295% on Room AirLow-normal - monitor
Pulse Rate65 bpmNormal
Temperature99.3°F (37.4°C)Low-grade fever
RR26 cycles/minTachypnea - needs attention
GRBS191 mg/dLElevated - DM not controlled

Treatment:
  1. Inj. Fentanyl CIVI (Continuous Intravenous Infusion) @ 2 ml/hr
  2. Inj. Ketorolac 30 mg IV BD

Clinical Flags / Suggestions to Review:
  1. RR 26/min (Tachypnea): Elevated respiratory rate in a patient with bone and liver mets on opioids - rule out opioid-related respiratory depression, pleural effusion, or pulmonary mets. SpO2 of 95% on room air adds to concern.
  2. Ketorolac + HBsAg+ + Liver Mets: Ketorolac is an NSAID with known hepatotoxic potential. In a patient with active liver metastases and Hepatitis B, NSAID use carries significant risk of hepatic decompensation and GI bleeding. Review whether Ketorolac is appropriate here - consider substituting with Paracetamol IV (if liver function permits) or optimizing opioid dosing instead.
  3. GRBS 191 mg/dL: Suboptimal glycemic control. Review insulin regimen or sliding scale in the context of poor oral intake (hypoglycemia risk if on fixed-dose insulin with poor PO intake).
  4. Low-grade fever (99.3°F): May indicate infection, tumor fever, or HBV-related activity. Consider CBC, LFT, and blood cultures if not already done.
  5. Poor oral intake: Nutritional support (oral supplements, dietitian review, or NG feeds) should be considered given the oncologic diagnosis and poor intake.

Note: Ketorolac use should be specifically re-evaluated by the treating team given the combination of liver metastases, HBsAg positivity, and ongoing opioid therapy.
This is a shared conversation. Sign in to Orris to start your own chat.